Nociceptin(1-7) Reference: HY-P1319 Nociceptin (1-7) is the N-terminal bioactive fragment of nociceptin (HY-P0183). Nociceptin (1-7) is a potent ORL1 (NOP) receptor agonist with antinociceptive activity. Nociceptin (1-7) combines with nociceptin reduces hyperalgesia in vivo.
[Asp371]-Tyrosinase (369-377), human Reference: HY-P1919 Tyrosinase 369-377, human is a HLA-A2.1-restricted epitope derived from tyrosinase, has been used to develop tumor-targeted vaccines with mixed efficacy.
[pThr3]-CDK5 Substrate TFA Reference: HY-P1906A [pThr3]-CDK5 Substrate TFA is an effective Phospho-Thr3CDK5 Substrate. [pThr3]-CDK5 Substrate is derived from the sequence of the histone H1 peptide that docks in the active site of CDK5. [pThr3]-CDK5 Substrate is phosphorylated by CDK5 with a Km value of 6 µM.
Pramlintide acetate Reference: HY-P0058B Pramlintide acetate is a polypeptide analogue of human amylin. Pramlintide acetate, an antidiabetic agent, is antineoplastic in colorectal cancer.
Cyclosporin A-Derivative 3 Reference: HY-P3338 Cyclosporin A-Derivative 3 is a derivative of Cyclosporin A (HY-B0579) with calcineurin inhibition.
PACAP-Related Peptide (PRP), human Reference: HY-P1511 PACAP-Related Peptide (PRP), human is a 29 amino-acid region of the PACAP precursor protein.